Arcutis Biotherapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ARQT Nasdaq 2836 www.arcutis.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Arcutis Biotherapeutics, Inc.

Arcutis to Report Third Quarter 2026 Financial Results and Host Conference Call on November 4, 2026 - Oct 21st, 2026 2:00 pm
Arcutis Biotherapeutics (ARQT) Gets New Rating Uprgades from 2 Analysts; Shares Climb - Oct 19th, 2026 8:37 pm
Clinical Data Update Could Shape The Case For Arcutis Biotherapeutics Stock - Oct 19th, 2026 5:21 pm
Arcutis Soars 12% as Guggenheim Lifts Target to $44 on “Growing Conviction” in 2027 - Oct 19th, 2026 11:13 am
2 Stocks That Could Soar in Q4 - Oct 12th, 2026 5:05 am
Arcutis Biotherapeutics (ARQT) Showcased Fresh ZORYVE Data, Is It Still 28% Below Fair Value? - Oct 9th, 2026 11:14 pm
Arcutis Presents ZORYVE® (roflumilast) Data and Real-World Topical Corticosteroid Research at EADV and Fall Clinical - Oct 9th, 2026 6:00 am
Arcutis’ ZORYVE® (roflumilast) Wins 2026 Marie Claire Beauty Award - Oct 6th, 2026 6:19 am
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Oct 2nd, 2026 2:00 pm
Merck's Tulisokibart Meets Endpoints in Hidradenitis Suppurativa Study - Oct 1st, 2026 6:55 am
Simone Biles Partners with Arcutis to Launch the Skin to Believe In Campaign, Raising Awareness of Seborrheic Dermatitis and Eczema, and Inspiring People to Explore Treatment Options - Sep 29th, 2026 7:15 am
AXT Inc. (AXTI) Climbs 16% on S&P 600 Addition - Sep 21st, 2026 2:00 pm
Strength Seen in Orchestra BioMed Holdings, Inc. (OBIO): Can Its 5.2% Jump Turn into More Strength? - Sep 21st, 2026 5:33 am
RHHBY's Lunsumio Combo Meets Goal in 2L Follicular Lymphoma Study - Sep 17th, 2026 8:48 am
Arcutis Biotherapeutics (ARQT) Moves 11.2% Higher: Will This Strength Last? - Sep 17th, 2026 8:38 am
Here’s What Arcutis’ CEO Said at the Morgan Stanley Healthcare Conference That Made the Stock Jump 11% - Sep 17th, 2026 1:20 am
Bloom Energy, Illumina, and Everpure Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600 - Sep 4th, 2026 5:15 pm
Arcutis Management to Present at the Morgan Stanley 24th Annual Global Healthcare Conference - Sep 2nd, 2026 2:00 pm
Here's Why You Should Add ARQT Stock to Your Portfolio Now - Aug 28th, 2026 8:58 am